nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—ABCB1—Lisinopril—dilated cardiomyopathy	0.232	0.532	CbGbCtD
Dihydroergotamine—ABCB1—Spironolactone—dilated cardiomyopathy	0.204	0.468	CbGbCtD
Dihydroergotamine—HTR2B—cardial valve—dilated cardiomyopathy	0.0501	0.878	CbGeAlD
Dihydroergotamine—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.0104	0.0319	CcSEcCtD
Dihydroergotamine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00732	0.0225	CcSEcCtD
Dihydroergotamine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00703	0.0217	CcSEcCtD
Dihydroergotamine—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.0064	0.0197	CcSEcCtD
Dihydroergotamine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00597	0.0184	CcSEcCtD
Dihydroergotamine—Bladder pain—Furosemide—dilated cardiomyopathy	0.00551	0.017	CcSEcCtD
Dihydroergotamine—Mental disability—Furosemide—dilated cardiomyopathy	0.00528	0.0163	CcSEcCtD
Dihydroergotamine—Bromocriptine—ADRB1—dilated cardiomyopathy	0.00513	1	CrCbGaD
Dihydroergotamine—Swelling—Furosemide—dilated cardiomyopathy	0.00501	0.0154	CcSEcCtD
Dihydroergotamine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0047	0.0145	CcSEcCtD
Dihydroergotamine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00457	0.0141	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00454	0.014	CcSEcCtD
Dihydroergotamine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00446	0.0137	CcSEcCtD
Dihydroergotamine—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00444	0.0137	CcSEcCtD
Dihydroergotamine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00444	0.0137	CcSEcCtD
Dihydroergotamine—Malaise—Spironolactone—dilated cardiomyopathy	0.00441	0.0136	CcSEcCtD
Dihydroergotamine—Cystitis—Lisinopril—dilated cardiomyopathy	0.00441	0.0136	CcSEcCtD
Dihydroergotamine—Photophobia—Lisinopril—dilated cardiomyopathy	0.00429	0.0132	CcSEcCtD
Dihydroergotamine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00413	0.0127	CcSEcCtD
Dihydroergotamine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00412	0.0127	CcSEcCtD
Dihydroergotamine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00403	0.0124	CcSEcCtD
Dihydroergotamine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00398	0.0123	CcSEcCtD
Dihydroergotamine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0039	0.012	CcSEcCtD
Dihydroergotamine—Injury—Lisinopril—dilated cardiomyopathy	0.00361	0.0111	CcSEcCtD
Dihydroergotamine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00355	0.0109	CcSEcCtD
Dihydroergotamine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00353	0.0109	CcSEcCtD
Dihydroergotamine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00338	0.0104	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00329	0.0101	CcSEcCtD
Dihydroergotamine—Face oedema—Lisinopril—dilated cardiomyopathy	0.0032	0.00986	CcSEcCtD
Dihydroergotamine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00317	0.00977	CcSEcCtD
Dihydroergotamine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00316	0.00972	CcSEcCtD
Dihydroergotamine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00299	0.0092	CcSEcCtD
Dihydroergotamine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00295	0.00908	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00294	0.00906	CcSEcCtD
Dihydroergotamine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00285	0.00878	CcSEcCtD
Dihydroergotamine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00283	0.0087	CcSEcCtD
Dihydroergotamine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00282	0.00869	CcSEcCtD
Dihydroergotamine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00279	0.0086	CcSEcCtD
Dihydroergotamine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00279	0.0086	CcSEcCtD
Dihydroergotamine—HTR2B—heart—dilated cardiomyopathy	0.00277	0.0485	CbGeAlD
Dihydroergotamine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00276	0.00849	CcSEcCtD
Dihydroergotamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00273	0.00842	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00266	0.00821	CcSEcCtD
Dihydroergotamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00264	0.00813	CcSEcCtD
Dihydroergotamine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00256	0.00788	CcSEcCtD
Dihydroergotamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00254	0.00782	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00252	0.00776	CcSEcCtD
Dihydroergotamine—Rash—Spironolactone—dilated cardiomyopathy	0.00252	0.00776	CcSEcCtD
Dihydroergotamine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00252	0.00775	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00251	0.00772	CcSEcCtD
Dihydroergotamine—Headache—Spironolactone—dilated cardiomyopathy	0.0025	0.00771	CcSEcCtD
Dihydroergotamine—Agitation—Furosemide—dilated cardiomyopathy	0.00245	0.00754	CcSEcCtD
Dihydroergotamine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00241	0.00743	CcSEcCtD
Dihydroergotamine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.0024	0.00739	CcSEcCtD
Dihydroergotamine—Vertigo—Furosemide—dilated cardiomyopathy	0.00239	0.00737	CcSEcCtD
Dihydroergotamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00237	0.00731	CcSEcCtD
Dihydroergotamine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.0023	0.00709	CcSEcCtD
Dihydroergotamine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00228	0.00701	CcSEcCtD
Dihydroergotamine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00222	0.00683	CcSEcCtD
Dihydroergotamine—Confusional state—Furosemide—dilated cardiomyopathy	0.00219	0.00675	CcSEcCtD
Dihydroergotamine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00214	0.00659	CcSEcCtD
Dihydroergotamine—Shock—Furosemide—dilated cardiomyopathy	0.00214	0.00658	CcSEcCtD
Dihydroergotamine—Flushing—Lisinopril—dilated cardiomyopathy	0.00213	0.00656	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.0021	0.00647	CcSEcCtD
Dihydroergotamine—Anorexia—Furosemide—dilated cardiomyopathy	0.00207	0.00638	CcSEcCtD
Dihydroergotamine—Chills—Lisinopril—dilated cardiomyopathy	0.00206	0.00634	CcSEcCtD
Dihydroergotamine—Hypotension—Furosemide—dilated cardiomyopathy	0.00203	0.00625	CcSEcCtD
Dihydroergotamine—Tension—Lisinopril—dilated cardiomyopathy	0.00196	0.00604	CcSEcCtD
Dihydroergotamine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00195	0.00601	CcSEcCtD
Dihydroergotamine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00194	0.00598	CcSEcCtD
Dihydroergotamine—Somnolence—Furosemide—dilated cardiomyopathy	0.00193	0.00595	CcSEcCtD
Dihydroergotamine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00192	0.00591	CcSEcCtD
Dihydroergotamine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00189	0.00582	CcSEcCtD
Dihydroergotamine—Fatigue—Furosemide—dilated cardiomyopathy	0.00187	0.00577	CcSEcCtD
Dihydroergotamine—Tremor—Lisinopril—dilated cardiomyopathy	0.00187	0.00576	CcSEcCtD
Dihydroergotamine—Pain—Furosemide—dilated cardiomyopathy	0.00186	0.00572	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00185	0.00571	CcSEcCtD
Dihydroergotamine—Malaise—Lisinopril—dilated cardiomyopathy	0.0018	0.00555	CcSEcCtD
Dihydroergotamine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00179	0.00553	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00179	0.00551	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00178	0.00547	CcSEcCtD
Dihydroergotamine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00177	0.00544	CcSEcCtD
Dihydroergotamine—ADRA2A—heart—dilated cardiomyopathy	0.00174	0.0305	CbGeAlD
Dihydroergotamine—Urticaria—Furosemide—dilated cardiomyopathy	0.00173	0.00532	CcSEcCtD
Dihydroergotamine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00172	0.00529	CcSEcCtD
Dihydroergotamine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00172	0.00529	CcSEcCtD
Dihydroergotamine—Myalgia—Lisinopril—dilated cardiomyopathy	0.0017	0.00524	CcSEcCtD
Dihydroergotamine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.0017	0.00524	CcSEcCtD
Dihydroergotamine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00169	0.00522	CcSEcCtD
Dihydroergotamine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00168	0.00517	CcSEcCtD
Dihydroergotamine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00166	0.00512	CcSEcCtD
Dihydroergotamine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00164	0.00506	CcSEcCtD
Dihydroergotamine—Oedema—Lisinopril—dilated cardiomyopathy	0.00163	0.00502	CcSEcCtD
Dihydroergotamine—Shock—Lisinopril—dilated cardiomyopathy	0.0016	0.00494	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0016	0.00493	CcSEcCtD
Dihydroergotamine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00159	0.0049	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00158	0.00485	CcSEcCtD
Dihydroergotamine—Asthenia—Furosemide—dilated cardiomyopathy	0.00156	0.0048	CcSEcCtD
Dihydroergotamine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00155	0.00479	CcSEcCtD
Dihydroergotamine—Pruritus—Furosemide—dilated cardiomyopathy	0.00154	0.00473	CcSEcCtD
Dihydroergotamine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00152	0.00469	CcSEcCtD
Dihydroergotamine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00149	0.0261	CbGeAlD
Dihydroergotamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00149	0.00458	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00149	0.00457	CcSEcCtD
Dihydroergotamine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00147	0.00454	CcSEcCtD
Dihydroergotamine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00146	0.00451	CcSEcCtD
Dihydroergotamine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00145	0.00448	CcSEcCtD
Dihydroergotamine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00145	0.00446	CcSEcCtD
Dihydroergotamine—Dizziness—Furosemide—dilated cardiomyopathy	0.00144	0.00443	CcSEcCtD
Dihydroergotamine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00143	0.00442	CcSEcCtD
Dihydroergotamine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00142	0.00436	CcSEcCtD
Dihydroergotamine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00141	0.00433	CcSEcCtD
Dihydroergotamine—Pain—Lisinopril—dilated cardiomyopathy	0.00139	0.00429	CcSEcCtD
Dihydroergotamine—Vomiting—Furosemide—dilated cardiomyopathy	0.00138	0.00425	CcSEcCtD
Dihydroergotamine—Rash—Furosemide—dilated cardiomyopathy	0.00137	0.00422	CcSEcCtD
Dihydroergotamine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00137	0.00422	CcSEcCtD
Dihydroergotamine—Headache—Furosemide—dilated cardiomyopathy	0.00136	0.00419	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00134	0.00414	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00133	0.00411	CcSEcCtD
Dihydroergotamine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00129	0.00399	CcSEcCtD
Dihydroergotamine—Nausea—Furosemide—dilated cardiomyopathy	0.00129	0.00397	CcSEcCtD
Dihydroergotamine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00129	0.00397	CcSEcCtD
Dihydroergotamine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00129	0.00397	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.0012	0.0037	CcSEcCtD
Dihydroergotamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00117	0.0036	CcSEcCtD
Dihydroergotamine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00115	0.00355	CcSEcCtD
Dihydroergotamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00112	0.00344	CcSEcCtD
Dihydroergotamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00108	0.00332	CcSEcCtD
Dihydroergotamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00104	0.00319	CcSEcCtD
Dihydroergotamine—Rash—Lisinopril—dilated cardiomyopathy	0.00103	0.00317	CcSEcCtD
Dihydroergotamine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00103	0.00316	CcSEcCtD
Dihydroergotamine—Headache—Lisinopril—dilated cardiomyopathy	0.00102	0.00315	CcSEcCtD
Dihydroergotamine—ABCB1—heart—dilated cardiomyopathy	0.000969	0.017	CbGeAlD
Dihydroergotamine—Nausea—Lisinopril—dilated cardiomyopathy	0.000968	0.00298	CcSEcCtD
Dihydroergotamine—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000316	0.00179	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000315	0.00178	CbGpPWpGaD
Dihydroergotamine—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000309	0.00175	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000308	0.00175	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000308	0.00174	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000307	0.00174	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000299	0.00169	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000298	0.00169	CbGpPWpGaD
Dihydroergotamine—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000296	0.00168	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000291	0.00165	CbGpPWpGaD
Dihydroergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000291	0.00164	CbGpPWpGaD
Dihydroergotamine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000272	0.00154	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000272	0.00154	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000266	0.0015	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000263	0.00149	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000261	0.00148	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000261	0.00148	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000258	0.00146	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000258	0.00146	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000256	0.00145	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000255	0.00144	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000253	0.00143	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000253	0.00143	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000253	0.00143	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000251	0.00142	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000251	0.00142	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00025	0.00141	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000246	0.00139	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000246	0.00139	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000242	0.00137	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000242	0.00137	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000242	0.00137	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000241	0.00136	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00024	0.00136	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.000237	0.00134	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000236	0.00133	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000236	0.00133	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000235	0.00133	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000235	0.00133	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000234	0.00132	CbGpPWpGaD
Dihydroergotamine—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000233	0.00132	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000231	0.00131	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000231	0.00131	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00023	0.0013	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00023	0.0013	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000229	0.00129	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000228	0.00129	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000228	0.00129	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000228	0.00129	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000226	0.00128	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000223	0.00126	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000223	0.00126	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000222	0.00125	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000221	0.00125	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000215	0.00122	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000215	0.00122	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000214	0.00121	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000212	0.0012	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000211	0.00119	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00021	0.00119	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00021	0.00119	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000208	0.00118	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000208	0.00118	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000207	0.00117	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000205	0.00116	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000203	0.00115	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000201	0.00114	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0002	0.00113	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000199	0.00113	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000195	0.0011	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000195	0.0011	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000193	0.00109	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00019	0.00108	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000189	0.00107	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000189	0.00107	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000187	0.00106	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000187	0.00106	CbGpPWpGaD
Dihydroergotamine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000187	0.00106	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000186	0.00106	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000185	0.00105	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000185	0.00105	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000183	0.00104	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00018	0.00102	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000179	0.00102	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000178	0.00101	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000177	0.001	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000175	0.000993	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000175	0.000989	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000175	0.000988	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000174	0.000986	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000172	0.000972	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00017	0.000963	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00017	0.000963	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00017	0.000961	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000169	0.000955	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000169	0.000954	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000168	0.000949	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000166	0.000942	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000164	0.00093	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000164	0.000929	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000163	0.000923	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000161	0.000914	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000158	0.000896	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000153	0.000867	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000153	0.000867	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000153	0.000866	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000152	0.000859	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000149	0.000841	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000148	0.00084	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000147	0.000834	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000147	0.000834	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000144	0.000816	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000143	0.000812	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000142	0.000806	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000141	0.000798	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.00014	0.000793	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00014	0.00079	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000139	0.000789	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000137	0.000776	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000137	0.000775	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000137	0.000774	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000136	0.00077	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000136	0.000769	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000136	0.000769	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000135	0.000763	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000135	0.000763	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000134	0.000757	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000134	0.000757	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000133	0.000754	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000133	0.000751	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000132	0.000747	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000132	0.000747	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000132	0.000747	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000132	0.000747	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000131	0.000741	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000131	0.000741	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00013	0.000737	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000129	0.000731	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000127	0.000716	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000126	0.000715	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000125	0.000709	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000125	0.000708	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000124	0.000704	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000124	0.000704	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000124	0.000703	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000124	0.000702	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000124	0.000702	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000123	0.000699	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000123	0.000695	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000122	0.000692	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000121	0.000687	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000121	0.000684	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00012	0.000682	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000119	0.000673	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000119	0.000673	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000115	0.000652	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000114	0.000643	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000113	0.000641	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000113	0.000641	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000112	0.000632	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000108	0.000609	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000107	0.000608	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000106	0.000601	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000104	0.000591	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000104	0.000587	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000103	0.000582	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000102	0.000574	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000101	0.000574	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000101	0.000572	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000101	0.000569	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000101	0.000569	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.91e-05	0.000561	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.83e-05	0.000557	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.76e-05	0.000552	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.64e-05	0.000546	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.63e-05	0.000545	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.53e-05	0.00054	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.35e-05	0.000529	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	9.21e-05	0.000521	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	9.15e-05	0.000518	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.05e-05	0.000512	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	9.05e-05	0.000512	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.05e-05	0.000512	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.9e-05	0.000504	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	8.75e-05	0.000495	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.64e-05	0.000489	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.62e-05	0.000488	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.57e-05	0.000485	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.52e-05	0.000482	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.45e-05	0.000478	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.39e-05	0.000475	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.34e-05	0.000472	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.27e-05	0.000468	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.97e-05	0.000451	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.9e-05	0.000447	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.9e-05	0.000447	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.88e-05	0.000446	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.77e-05	0.00044	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.73e-05	0.000438	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	7.69e-05	0.000435	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	7.63e-05	0.000432	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.58e-05	0.000429	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	7.48e-05	0.000423	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	7.35e-05	0.000416	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.35e-05	0.000416	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.34e-05	0.000415	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	7.29e-05	0.000413	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	7.24e-05	0.00041	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	7.14e-05	0.000404	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.12e-05	0.000403	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	7.02e-05	0.000397	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	6.71e-05	0.00038	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.39e-05	0.000362	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.3e-05	0.000357	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.08e-05	0.000344	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.92e-05	0.000335	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.88e-05	0.000333	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	5.83e-05	0.00033	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.77e-05	0.000326	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.75e-05	0.000326	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	5.69e-05	0.000322	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	5.68e-05	0.000321	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	5.44e-05	0.000308	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.41e-05	0.000306	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.24e-05	0.000297	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	5.11e-05	0.000289	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	5.1e-05	0.000289	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	5.06e-05	0.000287	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.02e-05	0.000284	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	4.96e-05	0.000281	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.95e-05	0.00028	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	4.66e-05	0.000264	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.48e-05	0.000253	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.38e-05	0.000248	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	4.28e-05	0.000242	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.03e-05	0.000228	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.93e-05	0.000222	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.78e-05	0.000214	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.54e-05	0.0002	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	3.5e-05	0.000198	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	3.47e-05	0.000196	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.45e-05	0.000195	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.4e-05	0.000192	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.19e-05	0.000181	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.97e-05	0.000168	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.59e-05	0.000147	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.48e-05	0.000141	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.42e-05	0.000137	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.18e-05	0.000123	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.04e-05	0.000115	CbGpPWpGaD
